Simris Group AB (PUBL) (FRA:5LU)

Market Cap	14.73M +119.8%
Revenue (ttm)	125.44K -46.2%
Net Income	-2.32M
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,000
Open	0.0056
Previous Close	0.0060
Day's Range	0.0056 - 0.0056
52-Week Range	0.0002 - 0.0110
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 11, 2026

About Simris Group AB (PUBL)

Simris Group AB (PUBL), a biotechnology company, develops antibody-drug conjugate (ADC) payloads in Sweden and internationally. The company develops, manufactures, and sells bioactive substances from cultured microalgae and cyanobacteria. It also offers cosmetics and skincare products; biopharmaceuticals; and dietary supplements. The company was incorporated in 2011 and is headquartered in Hammenhög, Sweden.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2011
• Employees: 5
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 5LU

Financial Performance

In 2025, Simris Group AB (PUBL)'s revenue was 1.62 million, a decrease of -44.12% compared to the previous year's 2.89 million. Losses were -26.81 million, -22.52% less than in 2024.

Financial numbers in SEK

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error